Cargando…
Adalimumab Therapy for Recalcitrant Pyoderma Gangrenosum
Objective: To describe a patient with treatment-refractory pyoderma gangrenosum and the outcome of a novel therapeutic approach. Methods: Case report and review of the literature. Results: A patient with inflammatory bowel disease developed severe pyoderma gangrenosum while receiving treatment with...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Open Science Company, LLC
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1687150/ https://www.ncbi.nlm.nih.gov/pubmed/17149453 |